0001140361-15-024197.txt : 20150612
0001140361-15-024197.hdr.sgml : 20150612
20150612182946
ACCESSION NUMBER: 0001140361-15-024197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150610
FILED AS OF DATE: 20150612
DATE AS OF CHANGE: 20150612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RINGOLD GORDON
CENTRAL INDEX KEY: 0001101713
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 15929692
MAIL ADDRESS:
STREET 1: 325 EAST MIDDLEFIELD AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc1.xml
FORM 4
X0306
4
2015-06-10
0
0001437402
ARDELYX, INC.
ARDX
0001101713
RINGOLD GORDON
C/O ARDELYX, INC.
34175 ARDENWOOD BLVD, SUITE 100
FREMONT
CA
94555
1
0
0
0
Common Stock
2015-06-10
4
P
0
10000
15.1880
A
10000
I
By IRA
Stock Option (Right to Buy)
14.60
2015-06-11
4
A
0
15000
0.00
A
2025-06-11
Common Stock
15000
15000
D
This transaction was executed in multiple trades in prices ranging from $14.915 to $15.43, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
/s/ Elizabeth Grammer, Attorney-in-Fact for Gordon Ringold
2015-06-12